ClinicalTrials.govpublic full text
Rituximab to Treat Neuropathy With Anti-MAG Antibodies
polyneuropathies, neuropathy, b cells, anti-mag, demyelination, mag, rituxan, monoclonal antibodies, retuximab, demyelinating neuropathy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968894
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.